Get started
222

CARSGEN THERAPEUTICS HLDGS LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

2171 chart


Full chart

2171 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.32 B‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.33 HKD
Net income (FY)
‪−826.31 M‬ HKD
Revenue (FY)
0.00 HKD
Shares float
‪351.01 M‬
Beta (1Y)
1.69

Employees


Employees (FY)
516
Change (1Y)
−23 −4.27%
Revenue / Employee (1Y)
0.00 HKD
Net income / Employee (1Y)
‪−205.02 K‬ HKD

About CARSGEN THERAPEUTICS HLDGS LTD


Sector
Health Technology
CEO
Zong Hai Li
Headquarters
Shanghai
Website
carsgen.com
Founded
2018
FIGI
BBG011BNS486
CARsgen Therapeutics Holdings Ltd. is a clinical-stage biopharmaceutical company, which engages in discovering, researching, and developing cell therapies. The firm focuses on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The company was founded by Zong Hai Li and Hua Mao Wang on February 9, 2018, and is headquartered in Shanghai, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

2171 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 2171 is 8.46 HKD — it has increased by 0.79% in the past 24 hours. Watch CARSGEN THERAPEUTICS HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange CARSGEN THERAPEUTICS HLDGS LTD stocks are traded under the ticker 2171.
2171 stock has risen by 50.00% compared to the previous week, the month change is a 63.17% rise, over the last year CARSGEN THERAPEUTICS HLDGS LTD has showed a −20.79% decrease.
We've gathered analysts' opinions on CARSGEN THERAPEUTICS HLDGS LTD future price: according to them, 2171 price has a max estimate of 7.85 HKD and a min estimate of 5.85 HKD. Watch 2171 chart and read a more detailed CARSGEN THERAPEUTICS HLDGS LTD stock forecast: see what analysts think of CARSGEN THERAPEUTICS HLDGS LTD and suggest that you do with its stocks.
2171 reached its all-time high on Oct 4, 2021 with the price of 57.25 HKD, and its all-time low was 2.48 HKD and was reached on Sep 5, 2024. View more price dynamics on 2171 chart.
See other stocks reaching their highest and lowest prices.
2171 stock is 24.01% volatile and has beta coefficient of 1.69. Track CARSGEN THERAPEUTICS HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is CARSGEN THERAPEUTICS HLDGS LTD there?
Today CARSGEN THERAPEUTICS HLDGS LTD has the market capitalization of ‪4.32 B‬, it has increased by 22.65% over the last week.
Yes, you can track CARSGEN THERAPEUTICS HLDGS LTD financials in yearly and quarterly reports right on TradingView.
CARSGEN THERAPEUTICS HLDGS LTD is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
2171 earnings for the last half-year are −0.68 HKD per share, whereas the estimation was −0.28 HKD, resulting in a −142.31% surprise. The estimated earnings for the next half-year are −0.43 HKD per share. See more details about CARSGEN THERAPEUTICS HLDGS LTD earnings.
CARSGEN THERAPEUTICS HLDGS LTD revenue for the last half-year amounts to ‪6.81 M‬ HKD, despite the estimated figure of ‪263.60 M‬ HKD. In the next half-year revenue is expected to reach ‪74.00 M‬ HKD.
2171 net income for the last half-year is ‪−380.96 M‬ HKD, while the previous report showed ‪−370.90 M‬ HKD of net income which accounts for −2.71% change. Track more CARSGEN THERAPEUTICS HLDGS LTD financial stats to get the full picture.
No, 2171 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 11, 2024, the company has 516.00 employees. See our rating of the largest employees — is CARSGEN THERAPEUTICS HLDGS LTD on this list?
Like other stocks, 2171 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARSGEN THERAPEUTICS HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARSGEN THERAPEUTICS HLDGS LTD technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARSGEN THERAPEUTICS HLDGS LTD stock shows the buy signal. See more of CARSGEN THERAPEUTICS HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.